Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2
- PMID: 15375219
- DOI: 10.1126/science.1102574
Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2
Abstract
Germ-line mutations inactivating BRCA2 predispose to cancer. BRCA2-deficient cells exhibit alterations in chromosome number (aneuploidy), as well as structurally aberrant chromosomes. Here, we show that BRCA2 deficiency impairs the completion of cell division by cytokinesis. BRCA2 inactivation in murine embryo fibroblasts (MEFs) and HeLa cells by targeted gene disruption or RNA interference delays and prevents cell cleavage. Impeded cell separation is accompanied by abnormalities in myosin II organization during the late stages in cytokinesis. BRCA2 may have a role in regulating these events, as it localizes to the cytokinetic midbody. Our findings thus link cytokinetic abnormalities to a hereditary cancer syndrome characterized by chromosomal instability and may help to explain why BRCA2-deficient tumors are frequently aneuploid.
Similar articles
-
Evidence that the tumor-suppressor protein BRCA2 does not regulate cytokinesis in human cells.J Cell Sci. 2010 May 1;123(Pt 9):1395-400. doi: 10.1242/jcs.068015. Epub 2010 Mar 31. J Cell Sci. 2010. PMID: 20356927
-
Interference with BRCA2, which localizes to the centrosome during S and early M phase, leads to abnormal nuclear division.Biochem Biophys Res Commun. 2007 Mar 30;355(1):34-40. doi: 10.1016/j.bbrc.2007.01.100. Epub 2007 Jan 26. Biochem Biophys Res Commun. 2007. PMID: 17286961
-
BRCA2 in mitotic exit: a new role in regulating genomic stability.Future Oncol. 2006 Feb;2(1):43-6. doi: 10.2217/14796694.2.1.43. Future Oncol. 2006. PMID: 16556071
-
A comprehensive analysis of BRCA2 gene: focus on mechanistic aspects of its functions, spectrum of deleterious mutations, and therapeutic strategies targeting BRCA2-deficient tumors.Med Oncol. 2018 Jan 31;35(3):18. doi: 10.1007/s12032-018-1085-8. Med Oncol. 2018. PMID: 29387975 Review.
-
BRCA2: breaks, mistakes and failed separations.Trends Mol Med. 2005 Apr;11(4):145-8. doi: 10.1016/j.molmed.2005.02.003. Trends Mol Med. 2005. PMID: 15823750 Review.
Cited by
-
SIK2 kinase synthetic lethality is driven by spindle assembly defects in FANCA-deficient cells.Mol Oncol. 2022 Feb;16(4):860-884. doi: 10.1002/1878-0261.13027. Epub 2021 Jun 28. Mol Oncol. 2022. PMID: 34058059 Free PMC article.
-
The phospho-dependent role of BRCA2 on the maintenance of chromosome integrity.Cell Cycle. 2021 Apr;20(8):731-741. doi: 10.1080/15384101.2021.1892994. Epub 2021 Mar 10. Cell Cycle. 2021. PMID: 33691600 Free PMC article. Review.
-
Minding the gap: the underground functions of BRCA1 and BRCA2 at stalled replication forks.DNA Repair (Amst). 2007 Jul 1;6(7):1018-31. doi: 10.1016/j.dnarep.2007.02.020. Epub 2007 Mar 26. DNA Repair (Amst). 2007. PMID: 17379580 Free PMC article. Review.
-
Development of thymic lymphomas in mice disrupted of Brca2 allele in the thymus.Exp Mol Med. 2008 Jun 30;40(3):339-44. doi: 10.3858/emm.2008.40.3.339. Exp Mol Med. 2008. PMID: 18587272 Free PMC article.
-
Identification of Selective Lead Compounds for Treatment of High-Ploidy Breast Cancer.Mol Cancer Ther. 2016 Jan;15(1):48-59. doi: 10.1158/1535-7163.MCT-15-0527. Epub 2015 Nov 19. Mol Cancer Ther. 2016. PMID: 26586723 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous